HealthEquity, Inc. $HQY Shares Bought by Russell Investments Group Ltd.

Key Points

• Russell Investments Group Ltd. increased its stake in HealthEquity, Inc. by 108.7% in the 1st quarter, owning 140,829 shares worth approximately $12.4 million.
• Multiple analysts have raised their price targets for HealthEquity, with the average price target now at $118.55, reflecting strong support for the stock.
• Insiders have sold a total of 291,744 shares of HealthEquity valued at $32.7 million in the last ninety days, with insiders owning only 1.50% of the company's stock following these transactions.

Russell Investments Group Ltd. lifted its position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 108.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 140,829 shares of the company's stock after purchasing an additional 73,358 shares during the period. Russell Investments Group Ltd. owned about 0.16% of HealthEquity worth $12,445,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Wealth Enhancement Advisory Services LLC increased its position in HealthEquity by 24.7% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 6,380 shares of the company's stock valued at $564,000 after acquiring an additional 1,265 shares during the period. Mirae Asset Global Investments Co. Ltd. increased its position in HealthEquity by 7,983.6% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 24,655 shares of the company's stock valued at $2,179,000 after acquiring an additional 24,350 shares during the period. GAMMA Investing LLC increased its position in HealthEquity by 25.9% in the 1st quarter. GAMMA Investing LLC now owns 1,571 shares of the company's stock valued at $139,000 after acquiring an additional 323 shares during the period. WCM Investment Management LLC acquired a new position in HealthEquity in the 1st quarter valued at about $20,230,000. Finally, Oppenheimer Asset Management Inc. increased its position in HealthEquity by 6.5% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 75,206 shares of the company's stock valued at $6,646,000 after acquiring an additional 4,614 shares during the period. Institutional investors and hedge funds own 99.55% of the company's stock.

Insider Transactions at HealthEquity

In related news, Director Jon Kessler sold 97,767 shares of the stock in a transaction on Friday, June 6th. The stock was sold at an average price of $112.05, for a total value of $10,954,792.35. Following the completion of the sale, the director directly owned 75,000 shares in the company, valued at approximately $8,403,750. This represents a 56.59% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Elimelech Rosner sold 58,000 shares of the stock in a transaction on Friday, June 6th. The shares were sold at an average price of $112.56, for a total value of $6,528,480.00. Following the completion of the sale, the executive vice president owned 75,689 shares of the company's stock, valued at approximately $8,519,553.84. This represents a 43.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 291,744 shares of company stock worth $32,705,007 in the last ninety days. Insiders own 1.50% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. The Goldman Sachs Group lifted their price objective on HealthEquity from $94.00 to $104.00 and gave the company a "neutral" rating in a report on Wednesday, June 4th. Wall Street Zen raised HealthEquity from a "hold" rating to a "buy" rating in a report on Friday, June 6th. Royal Bank Of Canada lifted their price objective on HealthEquity from $112.00 to $117.00 and gave the company an "outperform" rating in a report on Wednesday, June 4th. Raymond James Financial reaffirmed a "strong-buy" rating and issued a $120.00 target price (up previously from $115.00) on shares of HealthEquity in a research note on Tuesday, July 8th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on HealthEquity from $98.00 to $115.00 and gave the company a "buy" rating in a research note on Thursday, June 5th. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, HealthEquity has a consensus rating of "Buy" and an average target price of $118.55.

HealthEquity Trading Up 2.4%

HQY traded up $2.11 during trading on Thursday, hitting $91.15. The company's stock had a trading volume of 497,413 shares, compared to its average volume of 1,004,320. The firm's 50 day moving average price is $97.33 and its 200-day moving average price is $96.93. The company has a debt-to-equity ratio of 0.50, a current ratio of 4.06 and a quick ratio of 4.06. The stock has a market cap of $7.88 billion, a PE ratio of 66.51, a PEG ratio of 1.39 and a beta of 0.54. HealthEquity, Inc. has a twelve month low of $73.84 and a twelve month high of $116.65.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.81 by $0.16. The company had revenue of $330.80 million during the quarter, compared to the consensus estimate of $322.25 million. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%.During the same period in the previous year, the firm posted $0.80 EPS. HealthEquity has set its FY 2026 guidance at 3.610-3.78 EPS. On average, analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.